Effects of a Second-generation Mindfulness-based Intervention on Quality of Life, Pain Management, and Psycho-spiritual Wellbeing in Cancer Patients: A Randomised Controlled Trial

Launched by UNIVERSITY OF DERBY · Nov 15, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a program called Meditation Awareness Training (MAT) to see how it can help improve the quality of life, manage pain, and enhance overall wellbeing in cancer patients. The researchers believe that incorporating traditional Buddhist concepts, like understanding the nature of change and letting go, may offer deeper benefits compared to earlier mindfulness programs. By participating in MAT, they hope patients will find new ways to cope with their illness, reduce stress, and feel more spiritually connected.

To be eligible for the trial, participants need to be at least 18 years old and have been diagnosed with cancer (up to stage 3) within the last two years. They should be able to attend weekly online sessions for eight weeks and have access to the internet for video calls. The study will involve both surveys to measure changes and personal interviews to hear about participants' experiences after the program. The researchers are hopeful this trial will provide valuable insights into how mindfulness can be tailored to better support cancer patients on their journey.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Participants must be over the age of 18 and have received a cancer diagnosis, including any recurrences, within the last 24 months. Eligible diagnoses can range up to, but not exceed, stage 3 cancer at the start of the study.
• • Participants to be available to attend weekly 2-hour sessions for 8 weeks
• • Due to the nature of the online course, participants must have access to the Internet and use an electronic device capable of joining a video conference.
• Exclusion Criteria:
• • Those with a palliative diagnosis
• • Those who may not speak English fluently.